These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19274032)

  • 1. Stem cells and transplant vasculopathy.
    Boilson BA; McGregor CG
    Minerva Cardioangiol; 2009 Apr; 57(2):233-47. PubMed ID: 19274032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of progenitor cells in transplant arteriosclerosis.
    Hillebrands JL; Onuta G; Rozing J
    Trends Cardiovasc Med; 2005 Jan; 15(1):1-8. PubMed ID: 15795157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease?
    Hauptman PJ; Nakagawa T; Tanaka H; Libby P
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S173-80. PubMed ID: 8719481
    [No Abstract]   [Full Text] [Related]  

  • 4. [Circulating recipient cells contribute to graft coronary arteriosclerosis].
    Sata M; Hirata Y; Nagai R
    J Cardiol; 2002 Jan; 39(1):48-9. PubMed ID: 11828797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of proliferation signal inhibitors in the prevention and treatment of allograft vasculopathy in heart transplantation.
    Delgado JF; Manito N; Segovia J; Almenar L; Arizón JM; Campreciós M; Crespo-Leiro MG; Díaz B; González-Vílchez F; Mirabet S; Palomo J; Roig E; de la Torre JM
    Transplant Rev (Orlando); 2009 Apr; 23(2):69-79. PubMed ID: 19298938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac allograft vasculopathy: current concepts and treatment.
    Waller J; Brook NR; Nicholson ML
    Transpl Int; 2003 Jun; 16(6):367-75. PubMed ID: 12756523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular remodeling in transplant vasculopathy.
    Mitchell RN; Libby P
    Circ Res; 2007 Apr; 100(7):967-78. PubMed ID: 17431198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody and complement in transplant vasculopathy.
    Wehner J; Morrell CN; Reynolds T; Rodriguez ER; Baldwin WM
    Circ Res; 2007 Feb; 100(2):191-203. PubMed ID: 17272820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin slows heart transplant vasculopathy.
    SoRelle R
    Circulation; 2003 Jul; 108(1):e9001. PubMed ID: 12847063
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary artery vasculopathy in pediatric cardiac transplant patients: the therapeutic potential of immunomodulators.
    Pietra B; Boucek M
    Paediatr Drugs; 2003; 5(8):513-24. PubMed ID: 12895134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac allograft vasculopathy: recent developments.
    Schmauss D; Weis M
    Circulation; 2008 Apr; 117(16):2131-41. PubMed ID: 18427143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment.
    Pinney SP; Mancini D
    Curr Opin Cardiol; 2004 Mar; 19(2):170-6. PubMed ID: 15075747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid lineage of human endothelial outgrowth cells circulating in blood and vasculogenic endothelial-like cells in the diseased vessel wall.
    Liu C; Wang S; Metharom P; Caplice NM
    J Vasc Res; 2009; 46(6):581-91. PubMed ID: 19571578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric coronary allograft vasculopathy--a review of pathogenesis and risk factors.
    Schumacher KR; Gajarski RJ; Urschel S
    Congenit Heart Dis; 2012; 7(4):312-23. PubMed ID: 22176627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of transplant vasculopathy].
    Baron H; Plenz G; Deng MC
    Dtsch Med Wochenschr; 2004 Oct; 129(41):2193-7. PubMed ID: 15457400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of combined heart and kidney transplantation: a French multicenter study.
    Vermes E; Grimbert P; Sebbag L; Barrou B; Pouteil-Noble C; Pavie A; Obadia JF; Loisance D; Lang P; Kirsch M
    J Heart Lung Transplant; 2009 May; 28(5):440-5. PubMed ID: 19416771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac transplantation in the United States: an analysis of the UNOS registry.
    Everly MJ
    Clin Transpl; 2008; ():35-43. PubMed ID: 19708444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary angioscopy in the diagnosis of graft coronary artery disease in heart transplant recipients.
    Ventura HO; White CJ; Ramee SR; Collins TJ; Mesa JE; Jain A
    J Heart Lung Transplant; 1991; 10(3):488. PubMed ID: 1854778
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of CD14+ monocyte-derived progenitor cells with cardiac allograft vasculopathy.
    Salama M; Andrukhova O; Roedler S; Zuckermann A; Laufer G; Aharinejad S
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1246-53. PubMed ID: 22014346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.